News

27 April 2011
NEEDHAM, Massachusetts (USA) and GRENOBLE (FRA) – April 27, 2011 – The Drug Safety Executive Council (DSEC), an industry membership run by Cambridge Healthtech Associates (CHA), together with CYTOO, a provider of innovative products for the life science research and drug discovery markets with an emphasis in cell based assays, high content analysis and cell screening, today announced a new program as part of DSEC’s Technology Evaluation Consortium. The project will assess the scientific and economic utility of the ReferenceCell™, a technology that provides quantification of cell-based...
17 November 2010
CYTOOplates brings robustness, sensitivity and powerful quantification to cell-based assays and screening Grenoble, France and Framingham, Massachusetts, November 17, 2010 – CYTOO Cell Architects, a developer and marketer of innovative enabling technologies and products for High Content cell Analysis (HCA), today announced the commercial release of CYTOOplates™ 96. This represents the first in a series of products and services integral to CYTOO’s mission of bringing robustness, sensitivity and powerful quantification to cell-based assays and screening. CYTOOplates are ideal for pharma,...
15 June 2010
Top European scientists demonstrate CYTOO’s technology increases sensitivity and speed in cell analysis. Grenoble, France, June 15, 2010 – CYTOO SA, a developer and marketer of innovative enabling technologies and products for high content cell analysis (HCA), today announced the first results from the Institut Curie confirming a major advance in cell analysis made possible by adhesive micropatterns, a technology for which Cytoo holds an exclusive worldwide license. The Institut Curie team demonstrated that a rigorous quantification of the cell-wide internal organization could be...
12 December 2009
Company officials were joined at the ribbon cutting ceremony by Massachusetts Lieutenant Governor Timothy P Murray, Massachusetts Life Sciences Center President and CEO Dr. Susan Windham-Bannister, Deputy Director and General Counsel to the Massachusetts Department of Business and Technology George Ramirez representing the Massachusetts Office of International Trade & Investment, MassBio Economic Development Director Peter Abair, and other state and local officials.  
10 December 2009
The virtual one, of course, but still.... Out of over 3000 virtual skippers at the helm of their Imoca60 virtual boats racing across the virtual Atlantic in the same wind conditions as the real (courageous) skippers, the CYTOO boats reached Costa Rica first in the "confirmed entrepreneur" class.  
02 December 2009
French Cell Chip Maker CYTOO Raises $4.7M, Opens US Shop December 01, 2009  By Justin Petrone Looking to tap into demand for high-throughput, cell-based assays from North American customers, French startup CYTOO recently raised $4.7 million to help it establish a US subsidiary near Boston. Founded last year in Grenoble, CYTOO currently sells CYTOOchips, which each comprises a 2 cm x 2 cm glass surface containing 144 micropattern arrays that provide 20,000 micropatterns per chip.  CYTOOplates, glass-bottom microplates in 96- or 384-well format, where each well holds an array...
19 November 2009
Grenoble, France, and Framingham, MA, 17 November, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, announces today the opening of its wholly-owned U.S.-based subsidiary, CYTOO Inc., naming William T. Sharp president and CEO. Sharp also becomes a member of the Board of parent company Cytoo SA. Sharp, who brings 30 years’ life science tools, diagnostics, and clinical product market experience to CYTOO, will have worldwide responsibilities for sales and marketing. He will also be charged with setting up co-distribution and...
28 September 2009
Grenoble, France, 28 September, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, today announced the closing of a second funding round of USD 4.7M (EUR 3.2M). New investor, Auriga Partners, led the round. An existing investor Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also took part. CYTOO will use the financing to grow its business internationally, expand the team and further its research and development in an area that is attracting increasing scientific and industrial interest. “We are very...
24 September 2009
CYTOO has Marketing and Sales positions open in the USA Check out our Careers page
09 September 2009
The CYTOOchamber™ is a 35mm footprint device specially designed and manufactured for our 2x2cm² square CYTOOchip™ format which enables you to do high resolution timelapse microscopy. The CYTOOchamber uses a patented magnetic system (from Live Cell Instrument) for easy assembly. It is recommended for weak fluorescence signal observation. The CYTOOchamber has the same footprint as standard 35mm culture dishes and therefore will fit into all 35mm microscope stage adaptors.  

Pages